Five things to know:
1. U.S. sales grew 24 percent compared to the same period in 2021 with $51.1 million.
2. U.S. spinal implants and enabling technologies revenue of $27.4 million represents a 30 percent year-over-year increase.
3. U.S. orthobiologic sales of $23.8 million was an 18 percent increase year-over-year.
4. International sales leaped 207 percent compared to the third quarter of 2021 with $16 million.
5. SeaSpine saw a net loss of $15.5 million in the third quarter.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
